Literature DB >> 21879421

Factors associated with recurrence within 2 years after curative surgery for gastric adenocarcinoma.

Cheng-Yu Chiang1, Kuo-Hung Huang, Wen-Liang Fang, Chew-Wun Wu, Jen-Hao Chen, Su-Shin Lo, Mao-Chih Hsieh, King-Han Shen, Anna Fen-Yau Li, Dau-Ming Niu, Shih-Hwa Chiou.   

Abstract

BACKGROUND: Despite curative surgery for gastric cancer, many patients die of recurrent cancer. Few studies have investigated the time to recurrence after curative resection for gastric cancer.
METHODS: Data were collected prospectively between December 1987 and December 2006. A total of 1,549 patients underwent curative resection of adenocarcinoma of the stomach at Taipei Veterans General Hospital. Among them, 419 patients had recurrence; they were divided into early recurrence (<2 years) and late recurrence (≥2 years). The clinicopathological characteristics, survival time after recurrence, and recurrence patterns were compared between the two groups.
RESULTS: Multivariate analysis showed that stage III gastric cancer patients with early recurrence had larger tumors and more lymph node metastasis than patients with late recurrence, while no difference between early and late recurrence was observed in stage I and II patients. Early recurrence was associated with more distant metastasis than was late recurrence. Patients with advanced TNM stage tended to die within 2 years after recurrence.
CONCLUSIONS: Gastric cancer patients with larger tumors and more lymph node metastasis tended to have early recurrence, especially stage III patients. Advanced TNM stage was associated with early cancer death after recurrence.

Entities:  

Mesh:

Year:  2011        PMID: 21879421     DOI: 10.1007/s00268-011-1247-8

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  8 in total

1.  Prediction of early and late recurrence after curative resection for gastric carcinoma.

Authors:  Y Adachi; T Oshiro; M Mori; Y Maehara; K Sugimachi
Journal:  Cancer       Date:  1996-06-15       Impact factor: 6.860

2.  Time to death and pattern of death in recurrence following curative resection of gastric carcinoma: analysis based on depth of invasion.

Authors:  Eigo Otsuji; Yoshiaki Kuriu; Daisuke Ichikawa; Kazuma Okamoto; Toshiya Ochiai; Akeo Hagiwara; Hisakazu Yamagishi
Journal:  World J Surg       Date:  2004-09       Impact factor: 3.352

3.  Early and late recurrences after gastrectomy for gastric cancer: a multiple logistic regression analysis.

Authors:  Takashi Yokota; Toshihiro Saito; Shin Teshima; Yasuo Yamada; Kazutsugu Iwamoto; Michinori Takahashi; Shuichi Ishiyama; Katsuyuki Murata; Hidemi Yamauchi
Journal:  Ups J Med Sci       Date:  2002       Impact factor: 2.384

4.  Early and late recurrence after gastrectomy for gastric carcinoma. Univariate and multivariate analyses.

Authors:  N Shiraishi; M Inomata; N Osawa; K Yasuda; Y Adachi; S Kitano
Journal:  Cancer       Date:  2000-07-15       Impact factor: 6.860

5.  Predictors of timing and patterns of recurrence after curative resection for gastric cancer.

Authors:  Bang Wool Eom; Hongman Yoon; Keun Won Ryu; Jun Ho Lee; Soo Jeong Cho; Jong Yeul Lee; Chan Gyoo Kim; Il Ju Choi; Jong Seok Lee; Myung Cherl Kook; Sook Ryun Park; Byung-Ho Nam; Young-Woo Kim
Journal:  Dig Surg       Date:  2010-11-10       Impact factor: 2.588

6.  Timing of death from tumor recurrence after curative gastrectomy for gastric cancer.

Authors:  Burak Sakar; Hakan Karagol; Mahmut Gumus; Mert Basaran; Esra Kaytan; Andac Argon; Zeki Ustuner; Sevil E Bavbek; Dursun Bugra; Faruk N Aykan
Journal:  Am J Clin Oncol       Date:  2004-04       Impact factor: 2.339

7.  Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine.

Authors:  Shinichi Sakuramoto; Mitsuru Sasako; Toshiharu Yamaguchi; Taira Kinoshita; Masashi Fujii; Atsushi Nashimoto; Hiroshi Furukawa; Toshifusa Nakajima; Yasuo Ohashi; Hiroshi Imamura; Masayuki Higashino; Yoshitaka Yamamura; Akira Kurita; Kuniyoshi Arai
Journal:  N Engl J Med       Date:  2007-11-01       Impact factor: 91.245

8.  Pathology and prognosis of gastric carcinoma. Findings in 10,000 patients who underwent primary gastrectomy.

Authors:  K Nakamura; T Ueyama; T Yao; Z X Xuan; K Ambe; Y Adachi; Y Yakeishi; A Matsukuma; M Enjoji
Journal:  Cancer       Date:  1992-09-01       Impact factor: 6.860

  8 in total
  10 in total

1.  Postoperative follow-up programs improve survival in curatively resected gastric and junctional cancer patients: a propensity score matched analysis.

Authors:  Leila Sisic; Moritz J Strowitzki; Susanne Blank; Henrik Nienhueser; Sara Dorr; Georg Martin Haag; Dirk Jäger; Katja Ott; Markus W Büchler; Alexis Ulrich; Thomas Schmidt
Journal:  Gastric Cancer       Date:  2017-07-24       Impact factor: 7.370

2.  The prognostic significance of inflammation-based markers in patients with recurrent gastric cancer.

Authors:  Kazuhiro Migita; Sohei Matsumoto; Kohei Wakatsuki; Masahiro Ito; Tomohiro Kunishige; Hiroshi Nakade; Mutsuko Kitano; Mitsuhiro Nakatani; Masayuki Sho
Journal:  Surg Today       Date:  2017-08-23       Impact factor: 2.549

3.  Factors associated with early recurrence after curative surgery for gastric cancer.

Authors:  Wei-Ming Kang; Qing-Bin Meng; Jian-Chun Yu; Zhi-Qiang Ma; Zhi-Tian Li
Journal:  World J Gastroenterol       Date:  2015-05-21       Impact factor: 5.742

4.  Risk factors associated with splenic hilar lymph node metastasis in patients with advanced gastric cancer in northwest China.

Authors:  Zhenqiang Sun; Qisan Wang; Xianbo Yu; Chunlin Ou; Lizhong Yao; Kun Liu; Lin Liu; Lei Ge; Fa Fang; Zeliang Zhao; Haijiang Wang
Journal:  Int J Clin Exp Med       Date:  2015-11-15

5.  Combined epithelial-mesenchymal transition with cancer stem cell-like marker as predictors of recurrence after radical resection for gastric cancer.

Authors:  Gui-fang Xu; Wei-jie Zhang; Qi Sun; Xinyun Xu; Xiaoping Zou; Wenxian Guan
Journal:  World J Surg Oncol       Date:  2014-12-02       Impact factor: 2.754

6.  Research of shRNAmir inhibitory effects towards focal adhesion kinase expression in the treatment of gastric cancer.

Authors:  Guo-Qiang Su; Fu-Xing Zhang; He-Hui Mao; Xian-Wei Liu; Yong-Sheng Zheng; Si-Yu Zhang; Jing-Jun Su
Journal:  Oncol Lett       Date:  2014-11-21       Impact factor: 2.967

7.  The patterns and timing of recurrence after curative resection for gastric cancer in China.

Authors:  Dan Liu; Ming Lu; Jian Li; Zuyao Yang; Qi Feng; Menglong Zhou; Zhen Zhang; Lin Shen
Journal:  World J Surg Oncol       Date:  2016-12-08       Impact factor: 2.754

8.  Prognostic Factors and Recurrence Patterns in T4 Gastric Cancer Patients after Curative Resection.

Authors:  Bao-Yan Zhu; Shu-Qiang Yuan; Run-Cong Nie; Shu-Man Li; Li-Rong Yang; Jin-Ling Duan; Ying-Bo Chen; Xiao-Shi Zhang
Journal:  J Cancer       Date:  2019-01-29       Impact factor: 4.207

9.  Short-term safety and Long-term efficacy of multivisceral resection in pT4b gastric cancer patients without distant metastasis: a 20-year experience in China National Cancer Center.

Authors:  Xiaojie Zhang; Wanqing Wang; Lulu Zhao; Penghui Niu; Chunguang Guo; Dongbing Zhao; Yingtai Chen
Journal:  J Cancer       Date:  2022-08-15       Impact factor: 4.478

10.  A multicenter phase II study of biweekly capecitabine in combination with oxaliplatin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer.

Authors:  Yee Chao; Jan-Sing Hsieh; Hsien-Tang Yeh; Yu-Chieh Su; Cheng-Chung Wu; Jen-Shi Chen; Cheng-Jeng Tai; Li-Yuan Bai; Kun-Huei Yeh; Wu-Chou Su; Chung-Pin Li
Journal:  Cancer Chemother Pharmacol       Date:  2014-02-17       Impact factor: 3.333

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.